von Willebrand disease: from the bedside to therapy
- PMID: 9198216
von Willebrand disease: from the bedside to therapy
Abstract
Von Willebrand's disease was recognized by a careful observant clinician. Research advances in blood banking technology and molecular biology, in addition to astute clinical observation, have led to unraveling the factor VIII molecule, classification of a heterogenous disease, and rational therapy.
Similar articles
-
Treatment of von Willebrand's Disease.N Engl J Med. 2004 Aug 12;351(7):683-94. doi: 10.1056/NEJMra040403. N Engl J Med. 2004. PMID: 15306670 Review. No abstract available.
-
Treatment of von Willebrand's disease.Hematol Oncol Clin North Am. 1992 Oct;6(5):1079-94. Hematol Oncol Clin North Am. 1992. PMID: 1400073 Review.
-
[Hemostatic effect of deamino-8-D-arginine vasopressin (DDAVP) in hemophilia A and von Willebrand's disease].Rinsho Ketsueki. 1985 Jul;26(7):1069-79. Rinsho Ketsueki. 1985. PMID: 3932720 Japanese. No abstract available.
-
Structure and function of von Willebrand factor: relationship to von Willebrand's disease.Mayo Clin Proc. 1991 Aug;66(8):847-61. doi: 10.1016/s0025-6196(12)61204-x. Mayo Clin Proc. 1991. PMID: 1907344 Review.
-
Progress and problems in hemophilia and von Willebrand's disease.Adv Pediatr. 1984;31:137-77. Adv Pediatr. 1984. PMID: 6440429 No abstract available.